605116.SS
Price:
$21.69
Market Cap:
$8.77B
Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. It also provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Industry
Biotechnology
IPO Date
2020-09-21
Stock Exchange
SHH
Ticker
605116.SS
According to Aurisco Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 21.91. This represents a change of -9.86% compared to the average of 24.31 of the last 4 quarters.
The mean historical PE Ratio of Aurisco Pharmaceutical Co.,Ltd. over the last ten years is 45.56. The current 21.91 PE Ratio has changed 4.71% with respect to the historical average. Over the past ten years (40 quarters), 605116.SS's PE Ratio was at its highest in in the December 2022 quarter at 101.02. The PE Ratio was at its lowest in in the June 2019 quarter at 0.
Average
45.56
Median
40.48
Minimum
23.73
Maximum
100.42
Discovering the peaks and valleys of Aurisco Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.88%
Maximum Annual PE Ratio = 100.42
Minimum Annual Increase = -68.42%
Minimum Annual PE Ratio = 23.73
Year | PE Ratio | Change |
---|---|---|
2024 | 23.73 | -35.37% |
2023 | 36.72 | -21.76% |
2022 | 46.93 | -10.33% |
2021 | 52.34 | 29.31% |
2020 | 40.48 | 55.91% |
2019 | 25.96 | -18.13% |
2018 | 31.71 | -68.42% |
2017 | 100.42 | 93.88% |
The current PE Ratio of Aurisco Pharmaceutical Co.,Ltd. (605116.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
35.79
5-year avg
40.04
10-year avg
45.56
Aurisco Pharmaceutical Co.,Ltd.’s PE Ratio is less than Xiamen Amoytop Biotech Co., Ltd. (0), less than Guilin Sanjin Pharmaceutical Co., Ltd. (34.26), less than Anhui Anke Biotechnology (Group) Co., Ltd. (0), greater than null (15.92), greater than null (20.04),
Company | PE Ratio | Market cap |
---|---|---|
0 | $30.34B | |
34.26 | $7.97B | |
0 | $13.99B | |
15.92 | $0 | |
20.04 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurisco Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aurisco Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aurisco Pharmaceutical Co.,Ltd.'s PE Ratio?
How is the PE Ratio calculated for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?
What is the highest PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?
What is the 3-year average PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?
What is the 5-year average PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS)?
How does the current PE Ratio for Aurisco Pharmaceutical Co.,Ltd. (605116.SS) compare to its historical average?